发明公开
EP4291305A2 CONFORMATIONALLY CONSTRAINED GLUCAGON ANALOGUES AND THEIR USE IN GLUCAGON-SINGLE CHAIN INSULIN FUSION PROTEINS
审中-实审
![CONFORMATIONALLY CONSTRAINED GLUCAGON ANALOGUES AND THEIR USE IN GLUCAGON-SINGLE CHAIN INSULIN FUSION PROTEINS](/ep/2023/12/20/EP4291305A2/abs.jpg.150x150.jpg)
基本信息:
- 专利标题: CONFORMATIONALLY CONSTRAINED GLUCAGON ANALOGUES AND THEIR USE IN GLUCAGON-SINGLE CHAIN INSULIN FUSION PROTEINS
- 申请号:EP22753250.4 申请日:2022-02-09
- 公开(公告)号:EP4291305A2 公开(公告)日:2023-12-20
- 发明人: WEISS, Michael A. , JAROSINSKI, Mark A. , DHAYALAN, Balamurugan , VARAS-MOLINA, Nicolas Mauricio Jeset
- 申请人: The Trustees of Indiana University
- 申请人地址: US Bloomington, IN 47405 107 S. Indiana Avenue
- 代理机构: V.O.
- 优先权: US202163147611 P 20210209
- 国际公布: WO2022173807 20220818
- 主分类号: A61P3/10
- IPC分类号: A61P3/10 ; C07K14/605 ; C07K14/62 ; C07K14/435 ; A61K38/00 ; A61P5/48 ; C12N5/10
IPC结构图谱:
A | 人类生活必需 |
--A61 | 医学或兽医学;卫生学 |
----A61P | 化合物或药物制剂的治疗活性 |
------A61P3/00 | 治疗代谢疾病的药物 |
--------A61P3/08 | .用于葡萄糖体内平衡的药物 |
----------A61P3/10 | ..治疗高血糖症的药物,例如抗糖尿病药 |